Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.50
Ask: 41.50
Change: -0.75 (-1.80%)
Spread: 1.00 (2.469%)
Open: 41.75
High: 41.75
Low: 40.75
Prev. Close: 41.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Mon, 21st Sep 2020 16:08

Tuesday 22 September 
Judges Scientific PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Ergomed PLCHalf Year Results
ASA International Group PLCHalf Year Results
Alliance Pharma PLCHalf Year Results
Frenkel Topping Group PLCHalf Year Results
Parity Group PLCHalf Year Results
Bluefield Solar Income Fund LtdFull Year Results
Longboat Energy PLCHalf Year Results
NAHL GroupHalf Year Results
Tremor International LtdHalf Year Results
Litigation Capital Management LtdFull Year Results
Cambridge Cognition Holdings PLCHalf Year Results
Personal Group Holdings PLCHalf Year Results
Inspecs Group PLCHalf Year Results
Oriole Resources PLCHalf Year Results
Learning Technologies Group PLCHalf Year Results
Kingfisher PLCHalf Year Results
AG Barr PLCHalf Year Results
Town Centre SecuritiesFull Year Results
Mortgage Advice Bureau (Holdings) PLCHalf Year Results
ADES International Holding PLCHalf Year Results
Wednesday 23 September 
PZ Cussons PLCFull Year Results
Equals Group PLCHalf Year Results
Warpaint London PLCHalf Year Results
ECSC Group PLCHalf Year Results
Xeros Technology Group PLCHalf Year Results
LoopUp Group PLCHalf Year Results
CloudCall Group PLCHalf Year Results
Ten Entertainment Group PLCHalf Year Results
Origin Enterprises PLCFull Year Results
Staffline Group PLCHalf Year Results
Thursday 24 September 
CVS Group PLCFull Year Results
Smiths Group PLCFull Year Results
Go-Ahead Group PLCFull Year Results
SIG PLCHalf Year Results
GYG PLCHalf Year Results
Mitchells & Butlers PLCTrading Update
Safestay PLCHalf Year Results
Ebiquity PLCHalf Year Results
DFS Furniture PLCFull Year Results
Faron Pharmaceuticals LtdHalf Year Results
Pendragon PLCHalf Year Results
RTW Venture Fund LtdHalf Year Results
Cineworld Group PLCHalf Year Results
Funding Circle Hodlings PLCHalf Year Results
Baillie Gifford Shin Nippon PLCHalf Year Results
United Utilities Group PLCTrading Statement
Friday 25 September 
Camellia PLCHalf Year Results
Pennon Group PLCTrading Statement
Monday 28 September 
Brand Architekts Group PLCFull Year Results
7digital Group PLCHalf Year Results
Ceres Power Holdings PLCFull Year Results
Avacta Group PLCHalf Year Results
Instem PLCHalf Year Results
Chesnara PLCHalf Year Results
Reach PLCHalf Year Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2021 09:37

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Read more
1 Feb 2021 14:37

TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash

TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash

Read more
1 Feb 2021 09:25

Avacta joint venture with Daewoong raises $7.3m in series A funding

(Sharecast News) - Biotherapeutics developer Avacta Group announced on Monday that its joint venture with Daewoong Pharmaceutical, AffyXell Therapeutics, has closed a series A venture capital investment of $7.3m (£5.32m) to further develop its pipeline of next generation cell and gene therapies.

Read more
28 Jan 2021 14:42

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test

Read more
7 Jan 2021 13:51

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma

Read more
7 Jan 2021 08:58

Avacta enters licence agreement with Point Biopharma

(Sharecast News) - Cancer therapy and diagnostics developer Avacta Group has entered into a licence agreement with Point Biopharma, it announced on Thursday, to provide access to its 'preCISION' technology for the development of tumour-activated radiopharmaceuticals.

Read more
23 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

Read more
23 Dec 2020 08:56

Avacta submits clinical trial application for 'AVA6000' prodrug

(Sharecast News) - Cancer therapy developer Avacta Group has submitted a clinical trial application in the UK for a phase 1 first-in-human open label dose-escalation and expansion study of its lead 'preCISION' prodrug, 'AVA6000', in patients with locally-advanced or metastatic selected solid tumours, it announced on Wednesday.

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
21 Dec 2020 09:49

Avacta enters 'Affimer' licensing deal with Astrea Bioseparations

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a licensing agreement with Astrea Bioseparations, it announced on Monday, for the use of the 'Affimer' platform in affinity purification applications.

Read more
23 Nov 2020 15:20

Avacta reports 'significant progress' on Covid-19 test

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group announced "significant progress" in the development of a scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions on Monday.

Read more
22 Oct 2020 15:53

UK DIRECTOR DEALINGS SUMMARY: Dunkerton Buys More Superdry Shares

UK DIRECTOR DEALINGS SUMMARY: Dunkerton Buys More Superdry Shares

Read more
1 Oct 2020 06:40

IN BRIEF: Avacta Stock Continues Rise After Launch Of SARS-CoV-2 Test

IN BRIEF: Avacta Stock Continues Rise After Launch Of SARS-CoV-2 Test

Read more
24 Sep 2020 15:43

UK's Integumen unveils prototype COVID-19 breath test

LONDON, Sept 24 (Reuters) - Integumen, a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a personalised breath test that could become an effective tool in fighting...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.